Re-treatment with Highly Purified nIFNα in Mexican Nonresponder Patients with Chronic Genotype 1 Hepatitis C-Reference-Cited by-同舟云学术

Re-treatment with Highly Purified nIFNα in Mexican Nonresponder Patients with Chronic Genotype 1 Hepatitis C

Published:2013-08 Issue:6 Volume:44 Page:444-448
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Muñoz-Espinosa Linda E.,Cordero-Pérez Paula,Marín-López Eduardo,Torres-González Liliana,Malé-Velázquez Rene,Armienta-Sarabia Rolando,Hernández-Gómez María Elena,Núñez-Camarena José de Jesús Ernesto,Olivera-Martínez Marco Antonio,Sánchez-Avila Juan Francisco

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Diagnosis, management and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after non-response to pegylated interferon/ribavirin: DIRECT results;Bacon;Hepatology,2009

3. Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial;Fartoux;Clin Gastroenterol Hepatol,2007

4. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon;DiBisceglie;N Engl J Med,2008

5. Pegylated interferon alfa-2a (40kD) plus ribavirin (RBV) in prior non-responders to pegylated interferon alfa-2b (12kD)/RBV: final efficacy and safety outcomes of the REPEAT study [Abstract LB4];Jensen;Hepatology,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Production and characterization of thirteen human type-I interferon-α subtypes;Protein Expression and Purification;2014-11